SCHEMBL23645082

SCHEMBL23645082

C[C@H](N)C(=O)OCc1cccc2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SLC1A3 P43003 1/20 0.56
▸ SLC1A2 P43004 1/20 0.56
▸ SLC1A1 P43005 1/20 0.56
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ PARP10 Q53GL7 2/20 0.50
▸ EPHX1 P07099 1/20 0.49
▸ ATM Q13315 1/20 0.48
▸ TDP1 Q9NUW8 2/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ TACR1 P25103 1/20 0.45
▸ CARM1 Q86X55 1/20 0.45
▸ PRMT6 Q96LA8 1/20 0.45
▸ PARP15 Q460N3 1/20 0.45
▸ MTNR1A P48039 1/20 0.44
▸ CTNNB1 P35222 1/20 0.44
▸ LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8083878 0.89 SLC1A3 (0.52) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL12419177 0.83 EPHX1 (0.48) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL25034482 0.81 ATM (0.57) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL487420 0.80 KMT2A (0.55) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL1998527 0.80 MEN1 (0.59) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL28702056 0.80 TDP1 (0.56) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL21372579 0.80 TDP1 (0.56) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL903514 0.80 SLC1A3 (0.54) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL28535381 0.80 SLC1A3 (0.48) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL18671842 0.79 EPHX1 (0.47) SLC1A3SLC1A2SLC1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3851448-A1 ANTI-ERYTHROPOIETIN RECEPTOR PEPTIDE EPO-Med Inc. (JP) 2021-07-21 — — EP disclosed
Send feedback